Exzeo Group, Inc. (NYSE:XZO) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Exzeo Group, Inc. (NYSE:XZO) have earned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $26.00.

Several equities research analysts have recently weighed in on XZO shares. Citizens Jmp initiated coverage on shares of Exzeo Group in a research note on Monday, December 1st. They issued a “market outperform” rating and a $27.00 target price on the stock. Wall Street Zen upgraded shares of Exzeo Group to a “hold” rating in a report on Monday, November 17th. William Blair started coverage on shares of Exzeo Group in a research report on Monday, December 1st. They issued an “outperform” rating on the stock. Truist Financial initiated coverage on Exzeo Group in a research report on Monday, December 1st. They set a “buy” rating and a $25.00 target price for the company. Finally, Zacks Research raised Exzeo Group to a “hold” rating in a research note on Tuesday, December 2nd.

Exzeo Group Price Performance

NYSE:XZO opened at $17.63 on Tuesday. The company has a market cap of $1.60 billion and a price-to-earnings ratio of 70.52. The company has a 50 day moving average of $20.79. Exzeo Group has a 1 year low of $12.91 and a 1 year high of $24.60.

Exzeo Group (NYSE:XZO) last released its quarterly earnings results on Wednesday, December 10th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. The company had revenue of $55.17 million for the quarter, compared to analysts’ expectations of $54.40 million.

Insiders Place Their Bets

In related news, President Kevin Andrew Mitchell purchased 12,510 shares of Exzeo Group stock in a transaction that occurred on Thursday, December 18th. The shares were bought at an average price of $19.58 per share, with a total value of $244,945.80. Following the purchase, the president directly owned 715,135 shares of the company’s stock, valued at approximately $14,002,343.30. This represents a 1.78% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Suela Bulku acquired 10,020 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The shares were bought at an average price of $19.58 per share, with a total value of $196,191.60. Following the acquisition, the chief financial officer directly owned 314,874 shares in the company, valued at $6,165,232.92. This represents a 3.29% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 32,550 shares of company stock worth $637,329 over the last quarter.

Institutional Trading of Exzeo Group

A hedge fund recently bought a new stake in Exzeo Group stock. Legato Capital Management LLC bought a new position in Exzeo Group, Inc. (NYSE:XZO) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 60,828 shares of the company’s stock, valued at approximately $1,475,000. Legato Capital Management LLC owned 0.07% of Exzeo Group at the end of the most recent quarter.

Exzeo Group Company Profile

Exzeo provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Exzeo’s Insurance-as-a-Service (IaaS) platform, which we refer to as the “Exzeo Platform,” currently includes nine highly configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain.